Pharmacokinetics and pharmacodynamics of vildagliptin in healthy Chinese volunteers.

被引:0
|
作者
He, Y. L. [1 ]
Yin, Q. [2 ]
Deckert, F. [3 ]
Ligueros-Saylan, M. [4 ]
Wang, M. [4 ]
Jiang, J. [5 ]
Liu, D. [5 ]
Kjems, L. [1 ]
Dole, W. P. [1 ]
Hu, P. [5 ]
机构
[1] Novartis, Cambridge, MA USA
[2] Novartis, Beijing, Peoples R China
[3] Novartis, Basel, Switzerland
[4] Novartis, E Hanover, NJ USA
[5] Beijing Union Med Coll Hosp, Beijing, Peoples R China
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:S94 / S94
页数:1
相关论文
共 50 条
  • [1] Pharmacokinetics and Pharmacodynamics of Vildagliptin in Healthy Chinese Volunteers
    Hu, Pei
    Yin, Qi
    Deckert, Fabienne
    Jiang, Ji
    Liu, Dongyang
    Kjems, Lise
    Dole, William P.
    He, Yan-Ling
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 49 (01): : 39 - 49
  • [2] Effects of diltiazem on the pharmacokinetics and pharmacodynamics of methylprednisolone in healthy volunteers.
    Booker, BM
    Magee, MH
    Blum, RA
    Lates, CD
    Jusko, WJ
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (02) : P22 - P22
  • [3] Effects of age and gender on the pharmacokinetics and pharmacodynamics of argatroban in healthy volunteers.
    Hursting, MJ
    Joffrion, JL
    Brooks, RL
    [J]. BLOOD, 1996, 88 (10) : 3055 - 3055
  • [4] GENETIC PREDICTORS OF EXEMESTANE PHARMACOKINETICS AND PHARMACODYNAMICS IN HEALTHY HUMAN VOLUNTEERS.
    Gregory, B.
    Hussein, N. M.
    Simpson, J. D.
    Plunk, M. A.
    Murphy, M. A.
    Kamdem, L. K.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 : S7 - S7
  • [5] GENETIC PREDICTORS OF EXEMESTANE PHARMACOKINETICS AND PHARMACODYNAMICS IN HEALTHY HUMAN VOLUNTEERS.
    Gregory, B.
    Hussein, N. M.
    Simpson, J. D.
    Plunk, M. A.
    Murphy, M. A.
    Kamdem, L. K.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 : S90 - S90
  • [6] Pharmacodynamics of octreotide in healthy volunteers.
    Pyke, R
    Foschia, S
    Siletti, S
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1996, 59 (02) : PII25 - PII25
  • [7] Pharmacokinetics (PK) and pharmacodynamics (PD) of interferon β-1a in healthy volunteers.
    Buchwalder, PA
    Buclin, T
    Trinchard, I
    Munafo, A
    Biollaz, J
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 63 (02) : 166 - 166
  • [8] EFFECT OF ESOMEPRAZOLE ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF SMC021 IN HEALTHY VOLUNTEERS.
    Choi, L.
    Sivasubramanian, R.
    Bhad, P.
    Junker, U.
    Jones, J.
    Azria, M.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S125 - S125
  • [9] PHARMACOKINETICS OF SINGLE AND MULTIPLE DOSES OF MOGUISTEINE IN HEALTHY CHINESE VOLUNTEERS.
    Gou, Z.
    Xiang, J.
    Feng, P.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S114 - S114
  • [10] PHARMACOKINETICS AND PHARMACODYNAMICS OF PT302, A LONG ACTING EXENATIDE, IN HEALTHY VOLUNTEERS.
    Shin, D.
    Gu, N.
    Yoon, S.
    Seol, E.
    Lee, H.
    Lim, K.
    Jang, I.
    Shin, S.
    Yu, K.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S43 - S43